Todos Med Ltd (TOMDF)

[JoeForkeyBolo]

CEO on Twitter - 8/16/22

[JoeForkeyBolo]

Nothing prohibits a company from auditing their financial reports. SEC only requires 10-K to be audited. I'm not sure what the Israeli law requires. I'm not concerned enough to try to dig into it. If Todos wants their 10-Q audited by internal or external auditors, that's their option. To me the NT filing looks more strategic than necessary. They should report by Tuesday, August 23 - the end of the 5-day late filing window. Looking forward to understanding more about what Gerald mentioned regarding this in his tweets yesterday.

[Canna-Biz-Invest]

Just came across this company, crazy potential here from what i have seen so far.

[JPetroInc]

yeah - also Uplist my arse...!

WTH's wrong with this picture Gerald...???



AJMHO

[Sapientlife]

No uplisting TOMDF headed for GrayBook

[redspeed]

More spilled milk crying. The Todos didn't say the quarterly report was audited. Yeah, I know other companies have a bookkeeper slap the quarterly report together sometimes in one page. I like Todos filings are reviewed by auditors, but that's just me, a real shareholder.

Having another pair of eyes on it now will help with the uplist coming up.

[leslunier]

More BS from GC. 10Q's are not audited.

[GreeseMonkey]

Good deal. I'm buying more so I will get a lower price and more shares. Thanks.

[frans]

correct one is dumping

[JPetroInc]

Jon Najarian might well be dumping his load of compensation shares ...

for his name recognition involving TOMDF media coverage...



just sayin...

AJMHO

[redspeed]

Gerald Commissiong@G_Commish 1h
$TOMDF re: #MonkeyPox #saliva /lesion PCR validation update - going well in lab, all of Requisition /CPT coding / reporting updated into our Laboratory Information system. Now just awaiting wet lab test completion: expected over weekend so can announce right after 10Q is filed.

[velcro]

It's in GC's personal financial interest to get Uplisting

[theswordman]

Long Covid--everything that has been discussed HERE, months ago

exhausted immune system--viral reservoirs--inflammation--REACTIVATION of dormant virus

Nice to see a medical study validate last years' splintered treatise from posters at this board

https://www.science.org/content/article/blood-abnormalities-found-people-long-covid

[Sapientlife]

Again Gerald F’s the Shareholders!

[leslunier]

Missing the 10Q filing date doesn't help. This clown GC never learns

[DreyDreyDrey]

I was thinking about the same thing. But 20 cents seems very far away. About 10x of where we will be end of the week. Even if SP rallied to 20. So many people would take profits… Really it would have to be sustained at 20 cents. So the rally would be to 40 cents and then a sell off to 20. And 40 cents sounds like a million miles away. Maybe spring time?

[frans]

company sell into the market

[Marksch1]

Has Jon Najarian lost his juice? I dont watch cnbc anymore, but this guy keeps flogging todos and people keep selling any rallies that may result.

[velcro]

Slightly larger net loss? But significant income?
Although the Company’s net loss increased only slightly during the six months ended June 30, 2022, as compared with the six months ending June 30, 2021, there were some significant changes in individual items in the Company’s income statement.

[JoeForkeyBolo]

Even more CEO on Twitter - late filing

[Rokky57]

I would like to think that GC knows Israeli laws and so, when he says AFTER the 10Q he will buy, then it's probably legal for him to do so..

My advice to him is to buy TOMDF with vigor to show his confidence in the company to others that are on the fence to buy...

[JoeForkeyBolo]

That's right, it was a statement, not a question. He probably thought I was asking again because it was something we discussed during a phone conversation we had a few months back. Still, glad to hear he plans to buy after the release.

Hopefully we see other insiders buying as well. Insider buying should clearly be part of their strategy to drive realistic value prior to uplist. But I'm not familiar with how Israeli law handles insider transactions. I would guess it's much tigher than U.S. law since the lawyers have restricted insider buying for quite a while already. Gerald bought a number of times when heading up Amarantus, as the filings show. But Amarantus was based in the U.S., not Israel, so restrictions are probably stricter based on lack of insider buying so far. Anyone have any experience with Israeli insiders buying in an investment?

[Rokky57]

@JoeForkeyBolo ... You were stating to GC that YOU were still buying shares and in his response, he replied, " There will be news this week...and then YES I BUY."


GC misunderstood you to be asking him if he was buying shares while you were just disclosing that you are still buying shares..

Looks like after the 10Q, GC WILL be buying shares..

[JoeForkeyBolo]

Possibly another lockup agreement on conversions until uplist is in the works and will be announced this week. That would send a message to market and limit selling pressure by MMs who expect to easily be able to cover their short selling.

[GreeseMonkey]

Sh*t's about to get real. Todos is the real deal. Happy I own a bunch of shares, and buying more. GLTA

Interesting week ahead, and anxiously awaiting the 10-Q.

[JoeForkeyBolo]

More CEO on Twitter - late filing

[JoeForkeyBolo]

In trying to decipher Gerald's comment about "week's end" and "not vote but things around it", I believe this applies to the Pre-14A filing last week, which states:

All holders of our ordinary shares as of the close of business on August 19, 2022 (the “Record Date”), are entitled to vote at the meeting.

https://investor.todosmedical.com/sec-filings/all-sec-filings##document-429-0001140361-22-029420-1

This may indicate we will get news and a new 14A filing where one or more of the proposals to be voted on may change. I expect one change will be the RS ratio will be reduced from the 1:500 maximum, as that seems to be causing some concern among shareholders. Just my guess. Other opinions welcomed.

I would like to see GC follow through on the purchase of Todos shares. I think that will send a clear message to investors.

[JoeForkeyBolo]

Agreed, and mainstream media goes along with CDC in reporting downtrend in Covid. From person experience, I don't see it. Lots of folks at my work still getting Covid, some for the second or third go around. I've luckily avoided it but I've been taking Tollovid since it was first commercially available. I'm not usually wearing a mask, but I have been in close proximity to at least a couple of folks who tested positive shortly after my contact with them. I believe Tollovid was key in preventing my infection, or at least preventing it from taking hold if I was infected.

Still buying shares as long as price remains below my average cost. Don't expect that to last much longer.

[JoeForkeyBolo]

CEO on Twitter about NT 10-Q filing

[JoeForkeyBolo]

NT 10-Q filed - Notification of late filing

https://investor.todosmedical.com/sec-filings/all-sec-filings/content/0001493152-22-022913/0001493152-22-022913.pdf

[vcf5502]

I would be thrilled if the market would allow share price to reflect the true valuation of Todos. Problem is TOMDF is getting clumped together with all other OTC stocks, most of which have no real business, no products, no revenues etc etc. So what happens. The penny pinching day traders jump in on any good news, and then sell taking a quick hit profit, which does not let the SP get a good footing.

I am expecting a rock solid quarterly tomorrow, which in the real world would propel the SP. But probably will have little effect here in OTCQ land.

I think it is going to take a blockbuster announcement, such as an EUA which is broadcast on the national level before we will gain traction.

And here's to hoping GC holds off until then to apply for an R/S and uplist.

AMHO

[theswordman]

Covid continues

There are some here and prob everywhere that believe covid is over or it is now harmless etc. I don't see evidence--like real world data--not partial data and opinions that support that. We can all hope that is true . As a guy once said--trust but verify

https://scitechdaily.com/how-omicron-ba-5-became-a-master-of-disguise-what-it-means-for-the-current-covid-surge/

Just keep in mind--the more times you "catch" covid--the more times your immune system "fights" covid. The more there is T cell exhaustion/depletion. No one wants to go down that path. Worn immune system is what opens up long covid--longhauler--PASC. Call it what you want--but you don't want it.

[GreeseMonkey]

I expect share price would be well north of 20 cents before any RS is considered. When it was 8-10 cent range the RS was already approved and it wasn't done. So I believe GC when he says they are looking for realistic valuation in share price before RS is considered. The spinoff of 3CL Pharma may start the move to realistic valuation. Certainly a couple of EUAs will have an impact.

[Sapientlife]

No revenue from MonkeyPox EVER!

[vintagesake]

I believe it's ambs who owns shares of tomdf...70 some million..?

[DreyDreyDrey]

Do you still own AMBS? I thought Todos had a stake in them. With a small chance of success for Todos starting to look a little brighter. I would imagine you would take a more selfish stance and start to be objective. How closely is AMBS SP tied to TOMDF? Could investors recovery some of their equity? Or could AMBS negatively effect Todos… That would be one of those “surprises” I worry about.

[JPetroInc]

it's not the post date that's important ...

its simply Gerald's habitual Modus Operandi - is all ...

same old same old...!

AJMHO

[JoeForkeyBolo]

Thanks for posting the 7 year old tweets. It's a good reminder that the CEO has publicly stated he made mistakes with AMBS and is committed to not repeating them with Todos. The RS has been authorized for well over a year and he has not implemented the RS, which he stated would only be done after catalysts have moved the share price significantly higher than current levels.

Not much of a concern to most Todos shareholders, but thanks again for the reminder of past CEO mistakes which are driving better CEO decisions today.

[JPetroInc]

Gerald's fascination with RS's & Up-listings...



saying need to RS to get pps higher in order to gain access to capital markets financial resources is just another excuse to wash rinse & repeat the SS - SMH

AJMHO

[JPetroInc]

regurgitating these guys again...?

...overseen by Dr. Lee Morgentaler in concert with Andrew A. Blumenthal, RN ADS of two patients with Post-Acute Sequelae of COVID (PASC, or “Long COVID”)

SMH

[DreyDreyDrey]

With the stock at 2 or 3 cents. Just up off a penny. And a few flirts with 4 cents. What number could management be kicking around? A dime? 20 cents. Because from 2 cents to 20 cents is a 10x return. I would have to sell if the stock hit 20 cents. With several hundred thousand shares…

[Sloan89RH]

Press Release:

Todos Medical Reports Pre-Print of Publication Detailing Tollovid Supplementation Following COVID-19 mRNA Vaccination in Long COVID

https://investor.todosmedical.com/news-events/press-releases/detail/215/todos-medical-reports-pre-print-of-publication-detailing

[GreeseMonkey]

Company won't do the RS with share price as low as it is. CEO has stated this many times in interviews and on Twitter. Catalysts first, share price appreciation, then RS.

[velcro]

Correct. Isn't Quarterly Report tomorrow or very soon which will help immensely.

[DreyDreyDrey]

Doesn’t Todos have to have a SP over $5 for institutional investors to get on board? I think that is almost literally 500x if you want to clear the goal post with a little breathing room?!

[GreeseMonkey]

Todos is not a pump and dump like that other company with zero revenues and no product. Todos has millions in revenue and positive cash flow and it's increasing nicely. Looking forward to 10-Q today or tomorrow.

[GreeseMonkey]

I believe the 10B AS number is based on the maximum 1:500 RS ratio, whereby the 10B AS would be reduced to 20M. That being said, I don't believe the RS will be anywhere close to the 1:500 ratio.

[jFrank1]

Just found it:

Lawyers almost done. Videos shot. Platform https://t.co/rC0cA2wv6I

— Gerald Commissiong (@G_Commish) August 14, 2022

[freegriff]

Where did he tweet this?

[JPetroInc]

Agreed the COVID Sars 2 will be around in mutation form for some time - maybe not Monkeypox though - however, look at what else is around as I showed - a lot of nasty stuff is abound - regarding your solid core competency for testing in general ides was seriously offset by their MOTO+PARA's national mobile testing labs venture - which went caput in the middle of the night. So agreed again that a good idea and/or product does not guarantee success...but have to give an A for effort for those that hung in so far...

AJMHO